Thryv Therapeutics Inc. is a clinical-stage biotech pioneering precision medicine approaches to treating genetic arrhythmia syndromes and acquired cardiometabolic diseases through potent and highly selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1). For more information, please v... Read more
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
